世界的な健康問題に直面する中で、バイオテクノロジー起業家は、強靭で持続可能な医療システムの構築にどのように貢献できるのでしょうか？

Japan’s strengths in research present a major opportunity for scaling biotechnology start-ups. To address the challenge of limited access to entrepreneurship coaching and capital hindering global expansion, the Japan Society of Northern California (JSNC) and OviBees Ventures are implementing bioJent, a one-year entrepreneurship support program to build cultural and business ties between the U.S. and Japan, with a focus on venture capital and entrepreneurship coaching in the biotechnology sector.